Criteria for deciding cost-effectiveness for expensive new anti-cancer agents
J Cancer Res Ther
.
2008 Jan-Mar;4(1):1-2.
doi: 10.4103/0973-1482.39685.
Author
Rajiv Sarin
PMID:
18417893
DOI:
10.4103/0973-1482.39685
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / economics*
Antineoplastic Agents / therapeutic use*
Cost-Benefit Analysis*
Humans
Neoplasms / drug therapy*
Substances
Antineoplastic Agents